DATA PLANS
Download historical data for 20 million indicators using your browser.
Subscription Plans
|
Features
API GATEWAY
Direct access to our data from your apps using any programing language.
Features
|
Documentation
Already a user?
Login
Light Mode
Dark Mode
Calendar
News
Markets
Currencies
Stocks
Commodities
Bonds
Crypto
Earnings
Holidays
Indicators
Inflation Rate
Interest Rate
Unemployment Rate
GDP Growth
GDP per Capita
GDP Value
Current Account
Credit Rating
Wages Growth
Gold Reserves
Government Debt
Crude Oil Production
Gasoline Prices
Heatmap Table
More Indicators
Countries
United States
China
Japan
Canada
Australia
Brazil
Russia
India
Euro Area
United Kingdom
Germany
France
Italy
Spain
Switzerland
Singapore
More Countries
Forecasts
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
Crypto
Intercept Pharmaceuticals | ICPT - EPS Earnings Per Share
Chart
Quotes
Financials
Alerts
1Y
5Y
10Y
25Y
MAX
Chart
Column
Line
Area
Spline
Splinearea
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Compare
Export
API
Embed
Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Features
Questions?
Contact us
Already a Member?
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
API Features
Documentation
Interested?
Click here to contact us
Please Paste this Code in your Website
width
height
Preview
Intercept Pharmaceuticals
Intercept Pharmaceuticals reported $-0.77 in EPS Earnings Per Share for its fiscal quarter ending in March of 2023.
Fiscal
Calendar
Actual
Consensus
Previous
Date
FY2023Q1
Mar/2023
-0.77
-0.63
-0.58
Apr/27 2023
FY2022Q4
Dec/2022
-0.50
-0.43
-3.04
Mar/02 2023
FY2022Q3
Sep/2022
-3.04
-0.82
-0.11
Nov/01 2022
FY2022Q2
Jun/2022
-0.25
-0.46
-0.33
Aug/03 2022
FY2022Q1
Mar/2022
-0.58
-0.93
-1.22
May/06 2022
FY2021Q4
Dec/2021
-1.23
-1.04
-1.58
Mar/02 2022
FY2021Q3
Sep/2021
-0.11
-1.10
-2.01
Nov/03 2021
FY2021Q2
Jun/2021
-0.33
-1.22
-1.92
Jul/29 2021
FY2021Q1
Mar/2021
-1.22
-1.48
-2.86
May/06 2021
FY2020Q4
Dec/2020
-1.58
-1.48
-2.99
Feb/25 2021
FY2020Q3
Sep/2020
-2.01
-1.99
-2.59
Nov/09 2020
FY2020Q2
Jun/2020
-1.92
-2.94
-2.28
Aug/10 2020
Eps
Change
Date
Acadia Pharmaceuticals
ACAD:US
USD -0.27
0.01
Mar/2023
Acorda Therapeutics
ACOR:US
USD -0.69
1.26
Mar/2023
Alnylam Pharmaceuticals
ALNY:US
USD -1.4
0.28
Mar/2023
Amarin
AMRN:US
USD -0.04
0.04
Mar/2023
Amgen
AMGN:US
USD 3.98
0.11
Mar/2023
Arrowhead Research
ARWR:US
USD 0.45
0.84
Mar/2023
AstraZeneca
AZN:LN
USD 1.92
0.54
Mar/2023
Biogen
BIIB:US
USD 3.4
0.38
Mar/2023
Bluebird Bio
BLUE:US
USD 0.21
1.02
Mar/2023
Bristol-Myers Squibb
BMY:US
USD 2.05
0.23
Mar/2023
Eli Lilly
LLY:US
USD 1.62
0.47
Mar/2023
Enanta Pharmaceuticals
ENTA:US
USD -1.79
0.4
Mar/2023
Esperion Therapeutics
ESPR:US
USD -0.79
0.03
Mar/2023
Galectin Therapeutics
GALT:US
USD -0.19
0.01
Mar/2023
Gilead Sciences
GILD:US
USD 1.37
0.3
Mar/2023
GlaxoSmithKline
GSK:LN
GBP 0.37
0.11
Mar/2023
Incyte Corp
INCY:US
USD 0.37
0.25
Mar/2023
Intercept Pharmaceuticals
ICPT:US
USD -0.77
0.27
Mar/2023
Ionis Pharmaceuticals
IONS:US
USD -0.87
0.49
Mar/2023
Moderna Inc
MRNA:US
USD 0.19
3.42
Mar/2023
Neurocrine Biosciences
NBIX:US
USD -0.79
1.67
Mar/2023
Novartis
NOVN:VX
USD 1.71
0.19
Mar/2023
PTC Therapeutics
PTCT:US
USD -1.88
0.01
Mar/2023
Regeneron Pharmaceuticals
REGN:US
USD 10.09
2.47
Mar/2023
Sangamo BioSciences
SGMO:US
USD 0.12
0.44
Mar/2023
Sarepta Therapeutics
SRPT:US
USD -5.86
4.62
Mar/2023
Vertex Pharmaceuticals
VRTX:US
USD 3.05
0.71
Mar/2023
Financials
Stock Price
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
Employees
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Expense on Debt
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors